跳至主要内容
临床试验/NCT00589225
NCT00589225已完成不适用

Correlation of Disease Expression With Specific Genetic Mutations in Primary Hyperoxaluria

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 902 人开始时间: 2003年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
902
试验地点
1
主要终点
To determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria

研究概览

简要总结

This study will help us determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria.

详细描述

During your study visit, we will draw one tube, about two teaspoonfuls (1 to 1 ½ teaspoons for children), of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing. We will use the isolated DNA to try to identify the gene that is defective in Primary Hyperoxaluria by comparing it with the structure of genes in normal individuals, patients with Primary Hyperoxaluria, and family members of Primary Hyperoxaluria patients. In family members of primary hyperoxaluria patients, a 24 hour urine test may also be collected.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • You have been diagnosed, or you are in the process of being diagnosed Primary Hyperoxaluria
  • You have a family member diagnosed with Primary Hyperoxaluria

排除标准

  • 未提供

结局指标

主要结局

To determine whether certain genetic mutations, more than others, are a cause of more severe disease in Primary Hyperoxaluria

时间窗: 2 years

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dawn S. Milliner, M.D.

M.D.

Mayo Clinic

研究点 (1)

Loading locations...

相似试验